Piramal Pharma Ltd
NSE:PPLPHARMA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Piramal Pharma Ltd
NSE:PPLPHARMA
|
IN |
|
A
|
Andina Copper Corp
XTSX:ANDC
|
CA |
|
Hera SpA
OTC:HRASF
|
IT |
|
Axway Software SA
PAR:AXW
|
FR |
|
N
|
Novatek PAO
LSE:NVTK
|
RU |
|
Targa Resources Corp
NYSE:TRGP
|
US |
|
Vimeo Inc
NASDAQ:VMEO
|
US |
|
Symbotic Inc
NASDAQ:SYM
|
US |
|
Nordic American Tanker Ltd
NYSE:NAT
|
BM |
|
V
|
Vifor Pharma AG
SIX:VIFN
|
CH |
|
C
|
China Travel International Investment Hong Kong Ltd
HKEX:308
|
HK |
|
Fleury Michon SA
PAR:ALFLE
|
FR |
|
Lundin Gold Inc
TSX:LUG
|
CA |
|
F
|
FedEx Corp
F:FDX
|
US |
|
Rossari Biotech Ltd
NSE:ROSSARI
|
IN |
|
dotDigital Group PLC
LSE:DOTD
|
UK |
|
Topicus.com Inc
XTSX:TOI
|
CA |
|
V
|
Viking Holdings Ltd
NYSE:VIK
|
US |
|
A
|
Allied Gold Corp
OTC:AAUCF
|
CA |
|
NBT Bancorp Inc
NASDAQ:NBTB
|
US |
|
Al Nahdi Medical Company SCJSC
SAU:4164
|
SA |
|
Knowles Corp
NYSE:KN
|
US |
|
MAAS Group Holdings Ltd
ASX:MGH
|
AU |
|
I
|
Invesco Ltd
F:3IW
|
US |
Wall St Price Targets
PPLPHARMA Price Targets Summary
Piramal Pharma Ltd
According to Wall Street analysts, the average 1-year price target for PPLPHARMA is 210.43 INR with a low forecast of 176.75 INR and a high forecast of 267.75 INR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PPLPHARMA's stock price target?
Price Target
210.43
INR
According to Wall Street analysts, the average 1-year price target for PPLPHARMA is 210.43 INR with a low forecast of 176.75 INR and a high forecast of 267.75 INR.
What is the Revenue forecast for Piramal Pharma Ltd?
Projected CAGR
9%
Over the last 3 years, the compound annual growth rate for Revenue has been 44%. The projected CAGR for the next 4 years is 9%.
What is the Gross Profit forecast for Piramal Pharma Ltd?
Projected CAGR
10%
Over the last 3 years, the compound annual growth rate for Gross Profit has been 52%. The projected CAGR for the next 4 years is 10%.
What is the Operating Income forecast for Piramal Pharma Ltd?
Projected CAGR
14%
Over the last 3 years, the compound annual growth rate for Operating Income has been -7%. The projected CAGR for the next 4 years is 14%.
What is the Pre-Tax Income forecast for Piramal Pharma Ltd?
Projected CAGR
34%
Over the last 3 years, the compound annual growth rate for Pre-Tax Income has been -1%. The projected CAGR for the next 3 years is 34%.
What is the Net Income forecast for Piramal Pharma Ltd?
Projected CAGR
76%
Over the last 3 years, the compound annual growth rate for Net Income has been -36%. The projected CAGR for the next 4 years is 76%.
